SCHEMBL10615664

SCHEMBL10615664

COCc1cnc2nc(N)nc(N)c2n1

nearest known ligand 0.62

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 1/20 0.62
DHFR P00374 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5013975 0.86 NOS1 (0.61) NOS1DHFR
SCHEMBL10850465 0.84 NOS1 (0.71) NOS1DHFR
SCHEMBL8813993 0.83 NOS1 (0.61) NOS1DHFR
SCHEMBL10852865 0.83 NOS1 (0.82) NOS1DHFR
SCHEMBL10848710 0.83 NOS1 (0.58) NOS1DHFR
SCHEMBL6251731 0.81 NOS1 (0.55) NOS1DHFR
SCHEMBL14435374 0.81 NOS1 (0.55) NOS1DHFR
SCHEMBL30432658 0.81 NOS1 (0.55) NOS1DHFR
SCHEMBL26500537 0.80 NOS1 (0.62) NOS1DHFR
SCHEMBL14075489 0.80 NOS1 (0.54) NOS1DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0108890-B1 PHARMACEUTICALLY ACTIVE PTERIDINE DERIVATIVES THE WELLCOME FOUNDATION LIMITED (GB) 1988-12-07 EP disclosed
US-4701455-A NERVOUS SYSTEM DISORDERS, PARKINSON'S DISEASE BURROUGHS WELLCOME CO. (US) 1987-10-20 US disclosed
US-4587340-A ANTIDEPRESSANTS BURROUGHS WELLCOME CO. (US) 1986-05-06 US disclosed
EP-0108890-A2 Pharmaceutically active pteridine derivatives THE WELLCOME FOUNDATION LIMITED (GB) 1984-05-23 EP disclosed
US-4079056-A REACTING 2,4-DIAMINO-6-PTERIDINE-METHANOL-HBR WITH TRIPHENYLPHOSPHINE DIBROMIDE OR PHOSPHORUS TRIBROMIDE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH, EDUCATION AND WELFARE (US) 1978-03-14 US disclosed
US-4077957-A INTERMEDIATE FOR METHOTREXATE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH, EDUCATION AND WELFARE (US) 1978-03-07 US disclosed